Results
|
|
20941.
|
|
|
|
20942.
|
|
|
|
20943.
|
|
|
|
20944.
|
|
|
|
20945.
|
|
|
|
20946.
|
|
|
|
20947.
|
|
|
|
20948.
|
Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial. [electronic resource] by
- Popat, Rakesh
- Brown, Sarah R
- Flanagan, Louise
- Hall, Andrew
- Gregory, Walter
- Kishore, Bhuvan
- Streetly, Matthew
- Oakervee, Heather
- Yong, Kwee
- Cook, Gordon
- Low, Eric
- Cavenagh, Jamie
Producer: 20180116
In:
The Lancet. Haematology vol. 3
Availability: No items available.
|
|
|
20949.
|
|
|
|
20950.
|
|
|
|
20951.
|
|
|
|
20952.
|
|
|
|
20953.
|
|
|
|
20954.
|
|
|
|
20955.
|
|
|
|
20956.
|
|
|
|
20957.
|
|
|
|
20958.
|
|
|
|
20959.
|
|
|
|
20960.
|
|